Cited in boardrooms, legal proceedings & government briefings since 2017
Medical cannabis sales and registered patients in United Kingdom, 2025 actuals and the 2027 forecast. Forecasts to 2030 are in the United Kingdom data pack.
Medical sales, EUR
| Metric | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| Medical sales | €265.4m | €329.6m | €430.1m | |||
| Patients | 91,487 | 120,382 | 157,093 |
Forecasts to 2030 — sales, patients and the full United Kingdom series — are in the United Kingdom data pack, or scoped to your question in a bespoke brief.
See the data pack Request a briefSource: Prohibition Partners — Global Medical Cannabis Market Review (2026, updated April 2026) & The European Cannabis Report (2025)
The full data appendix behind the United Kingdom market update — imports, pricing, sizing scenarios, patients and product-level data across 11 sections, updated each edition.
Imports — dried cannabis, annual (kg)
Dried cannabis imports, kg — 2018–2024 actuals
Source: UK Home Office FOI & Prohibition Partners. Actuals to 2025 and the model forecast to 2032 are included in the full dataset.
Imports by country of origin (kg)
14 origin countries × 3 years
In the full dataset
Average price (GBP per gram)
8 years
In the full dataset
Available supply (kg)
9 years × 2 series
In the full dataset
Market sizing scenarios (GBP)
3 scenarios × 6 years
In the full dataset
Patient estimates
6 years
In the full dataset
Top clinics by web traffic (March 2026)
12 clinics
In the full dataset
Product counts & pricing by format (latest month)
4 formats
In the full dataset
Flower products by origin (March 2026)
12 origins
In the full dataset
Flower products by importer (March 2026)
10 portfolios
In the full dataset
Cannabinoid ratio distribution by format
3 formats
In the full dataset
The full United Kingdom deep dataset — imports, pricing, sizing scenarios, patients and product-level data across 11 sections, with CSV export — is sold as a one-off data pack.
Buy the United Kingdom datasetMay 2026 edition.
How United Kingdom’s framework got here, and what moves next.
Specialist prescribing legalised
The Misuse of Drugs Regulations 2001 are amended so specialist doctors can prescribe cannabis-based medicinal products.
Private clinic market emerges
With NHS prescribing effectively limited to a handful of licensed products, access grows through a strictly regulated private clinic and pharmacy market.
Government confirms the status quo
The government indicates it does not intend to make further changes to the specialist prescribing arrangement.
Patient base forecast to more than double
PP forecasts UK registered patients growing from around 91,000 in 2025 to more than 237,000 by 2029.
From International Cannabis Weekly, our free global briefing.
Business of Cannabis · №467 · 18 Sept 2026 · Medical
Business of Cannabis · №467 · 18 Sept 2026 · Business & Investment
HempToday · №467 · 18 Sept 2026 · Hemp & CBD
Business of Cannabis · №466 · 11 Sept 2026 · Hemp & CBD
Cannabis Health · №466 · 11 Sept 2026 · Health & Science
Cannabis Health · №466 · 11 Sept 2026 · Events & Industry
The UK’s estimated medical market size for 2025 is over €300 million.
The pace of regulatory growth in medical cannabis has been slow in the UK, however the rate of market development has been rapid. Patient numbers are rising significantly each year, alongside a growth in suppliers, clinics and pharmacies.
The UK’s market is open to new players and new suppliers, however it is a strictly regulated environment, with import licensing procedures in particular posing an obstacle to suppliers. Participation in the market requires strong relationships with the network of players operating in the industry.
The majority of market supply is through imports, although due to the nature of the UK’s regulatory frameworks, a large proportion of imports are of products which are legally classified as raw materials, with final manufacturing steps carried out domestically. As well as this, commercial domestic cultivation has been rising rapidly over the past year. Several UK players are now selling significant volumes of UK-cultivated flower in the market, and several more are gearing up to do the same.
In the full United Kingdom market data
Sizing, forecasts, pricing, trade flows and licensed operators — verified by PP’s analysts. Available as a data pack.
